Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Ongagna

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Diabetes & Metabolism|April 1, 1997
Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study GroupJ C Ongagna, C Levy-Marchal
Diabetologia|March 1, 1995
Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodiesJ C Ongagna, C Levy-Marchal
Clinical Biochemistry|April 12, 2005
Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetesJ C Ongagna, M Pinget, A Belcourt
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 29, 1998
Insulin measurements in haemolysed serum: influence of insulinase inhibitorsR Sapin, J C Ongagna, F Gasser, et al.
Clinical Biochemistry|March 10, 2001
The HLA-DQB alleles and amino acid variants of the vitamin D-binding protein in diabetic patients in AlsaceJ C Ongagna, M C Kaltenbacher, R Sapin, et al.
Revue Neurologique|February 21, 2012
[Multiple sclerosis without treatment: characteristic features of 70 untreated patients in a cohort of 1187 patients]Z Sekkat, J-C Ongagna, N Collongues, et al.
Revue Neurologique|September 8, 2015
[Difficulties experienced at work by patients with multiple sclerosis]J C Ongagna, A Passadori, J Pinelli, et al.
Journal of Neurology|August 28, 2009
Demographic and clinic characteristics of French patients treated with natalizumab in clinical practiceOlivier Outteryck, J-C Ongagna, H Zéphir, et al.
Infectious Diseases Now|October 11, 2021
Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern FranceM Martinot, M Eyriey, S Gravier, et al.
Hippokratia|March 27, 2024
Characteristic and outcome changes in inpatients with COVID-19 during the four pre - Omicron wavesM Martinot, M Eyriey, S Gravier, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Diabetes & Metabolism|April 1, 1997
Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study GroupJ C Ongagna, C Levy-Marchal
Diabetologia|March 1, 1995
Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodiesJ C Ongagna, C Levy-Marchal
Clinical Biochemistry|April 12, 2005
Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetesJ C Ongagna, M Pinget, A Belcourt
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 29, 1998
Insulin measurements in haemolysed serum: influence of insulinase inhibitorsR Sapin, J C Ongagna, F Gasser, et al.
Clinical Biochemistry|March 10, 2001
The HLA-DQB alleles and amino acid variants of the vitamin D-binding protein in diabetic patients in AlsaceJ C Ongagna, M C Kaltenbacher, R Sapin, et al.
Revue Neurologique|February 21, 2012
[Multiple sclerosis without treatment: characteristic features of 70 untreated patients in a cohort of 1187 patients]Z Sekkat, J-C Ongagna, N Collongues, et al.
Revue Neurologique|September 8, 2015
[Difficulties experienced at work by patients with multiple sclerosis]J C Ongagna, A Passadori, J Pinelli, et al.
Journal of Neurology|August 28, 2009
Demographic and clinic characteristics of French patients treated with natalizumab in clinical practiceOlivier Outteryck, J-C Ongagna, H Zéphir, et al.
Infectious Diseases Now|October 11, 2021
Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern FranceM Martinot, M Eyriey, S Gravier, et al.
Hippokratia|March 27, 2024
Characteristic and outcome changes in inpatients with COVID-19 during the four pre - Omicron wavesM Martinot, M Eyriey, S Gravier, et al.
Pageof 2